Anti-Alpha-Hemolysin Monoclonal Antibodies Mediate Protection against Staphylococcus aureus Pneumonia
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Staphylococcus aureus pneumonia is one of the most common invasive diseases caused by this human pathogen.S. aureus alpha-hemolysin, a pore-forming cytotoxin, is an essential virulence factor in the pathogenesis of pneumonia. Vaccine-based targeting of this toxin provides protection against lethal staphylococcal pneumonia in a murine model system, suggesting that a monoclonal antibody-based therapy may likewise prove to be efficacious for prevention and treatment of this disease. We report the generation of two distinct anti-alpha-hemolysin monoclonal antibodies that antagonize toxin activity, preventing human lung cell injury in vitro and protecting experimental animals against lethal S. aureus pneumonia. Each of these two monoclonal antibodies recognized an epitope within the first 50 amino acid residues of the mature toxin and blocked the formation of a stable alpha-hemolysin oligomer on the target cell surface. Active immunization with the first 50 amino acids of the toxin also conferred protection against S. aureus pneumonia. Together, these data reveal passive and active immunization strategies for prevention or therapy of staphylococcal pneumonia and highlight the potential role that a critical epitope may play in defining human susceptibility to this deadly disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, passive immunization with anti-Hla antibodies or active immunization with nontoxigenic Hla is protective in animal models of staphylococcal infection [108, 115].”
From Metal ion acquisition in Staphylococcus aureus: overcoming nutritional immunity (2012) · cites this paper as [115]
Citations
Cites
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,005
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Structure of Staphylococcal α-Hemolysin, a Heptameric Transmembrane Pore
Song, L., Hobaugh, M. R., Shustak, C., Cheley, S., Bayley, H., & Gouaux, J. E. (1996) · Science · doi:10.1126/science.274.5294.1859 · Cited by 2,377
Epidemiology and Outcomes of Health-care–Associated Pneumonia
Kollef, M. H., Shorr, A., Tabak, Y. P., Gupta, V., Liu, L. Z., & Johannes, R. S. (2005) · Chest · doi:10.1378/chest.128.6.3854 · Cited by 948
Alpha-toxin of Staphylococcus aureus
Bhakdi, S. C., & Tranum-Jensen, J. (1991) · Microbiological Reviews · doi:10.1128/mmbr.55.4.733-751.1991 · Cited by 885
The Economic Impact of Staphylococcus aureus Infection in New York City Hospitals
Rubin, R. J., Harrington, C. A., Poon, A., Dietrich, K., Greene, J. A., & Moiduddin, A. (1999) · Emerging Infectious Diseases · doi:10.3201/eid0501.990102 · Cited by 445 · cited 1×
“aureus (MRSA), confounding the delivery of appropriate treatment and resulting in reported mortality as high as 56% (1, 17, 24).”
BackgroundVaccine protection against Staphylococcus aureus pneumonia
Wardenburg, J. B., & Schneewind, O. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072208 · Cited by 407 · cited 5×
“S-transferase (GST)-HlaH35L was generated as previously described (5).”
BackgroundMethodInfluentialSurface Proteins and Exotoxins Are Required for the Pathogenesis of Staphylococcus aureus Pneumonia
Wardenburg, J. B., Patel, R. J., & Schneewind, O. (2007) · Infection and Immunity · doi:10.1128/iai.01313-06 · Cited by 348 · cited 1×
“aureus pneumonia, as strains lacking this pore-forming cytotoxin are avirulent in a murine model of disease (4).”
BackgroundClinical Characteristics and Treatment Patterns Among Patients With Ventilator-Associated Pneumonia
Kollef, M. H., Morrow, L. E., Niederman, M. S., Leeper, K. V., Anzueto, A., Benz-Scott, L., & Rodino, F. J. (2006) · Chest · doi:10.1378/chest.129.5.1210 · Cited by 322 · cited 1×
“aureus pneumonia, especially disease caused by virulent strains such as LAC/ USA300, is readily appreciated when surgical and intensive care patients that are highly susceptible to staphylococcal ventilator-associated pneumonias are considered (15, 25).”
BackgroundFinelli, L., Fiore, A., Dhara, R., Brammer, L., Shay, D. K., Kamimoto, L., Fry, A., Hageman, J., Gorwitz, R., Bresee, J., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2008-1336 · Cited by 312
Research works printed but not linked: 1
- 10.1128/mr.55.4.733-751.1991 · doi:10.1128/mr.55.4.733-751.1991 · Paper page
Cited by
Sepsis: a roadmap for future research
Cohen, J., Vincent, J.-L., Adhikari, N. K. J., Machado, F. R., Angus, D. C., Calandra, T., Jaton, K., Giulieri, S., Delaloye, J., Opal, S., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70112-x · Cited by 992
Staphylococcus aureus α-Toxin: Nearly a Century of Intrigue
Berube, B., & Wardenburg, J. (2013) · Toxins · doi:10.3390/toxins5061140 · Cited by 613
“Interestingly, antagonism of Hla by active or passive immunization affords protection in both the lung and the skin [30,107,108,116], highlighting the existing challenges in the field to understand how distinct cellular responses to α-toxin are integrated in the context of the tissue”
BackgroundStaphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases
Oliveira, D., Borges, A., & Simões, M. (2018) · Toxins · doi:10.3390/toxins10060252 · Cited by 485
Wilke, G. A., & Wardenburg, J. B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001815107 · Cited by 459
“Binding of radiolabeled Hla prepared as described previously (30) was assessed after treatment of 1 × 10(6) cells/500 μL with 0.”
MethodBasis of Virulence in Community-Associated Methicillin-Resistant Staphylococcus aureus
Otto, M. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134309 · Cited by 457
Metadata
- Authors
- Ragle, B. E., & Bubeck Wardenburg, J.
- Affiliations
- Departments of Microbiology
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2009-07
- Volume
- 77
- Issue
- 7
- Pages
- 2712-2718
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- PMC
- PMC2708543
- OpenAlex
- W2122714192
- Cited by
- 202
- References
- 32
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 7 · 2023: 8 · 2022: 6 · 2021: 3 · 2020: 9 · 2019: 12 · 2018: 12 · 2017: 10 · 2016: 16 · 2015: 19 · 2014: 20 · 2013: 14 · 2012: 16
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Infection and Immunity (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Chicago
- National Cancer Institute (P30CA014599)
- National Institute of Allergy and Infectious Diseases (U54AI057153)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (K-12-HD 00850, K12HD000850)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Keywords
- Staphylococcus aureus, alpha-hemolysin, monoclonal antibodies, staphylococcal pneumonia, pore-forming toxins, toxin oligomerization, epitope mapping, active immunization, passive immunization, lung injury, virulence factors
- MeSH terms
- Animals, Antibodies, Bacterial, Antibodies, Monoclonal, Bacterial Toxins, Cell Line, Hemolysin Proteins, Humans, Mice, Inbred C57BL, Models, Molecular, Pneumonia, Staphylococcal, Survival Analysis, Epitope Mapping, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti-Alpha-Hemolysin Monoclonal Antibodies Mediate Protection against Staphylococcus aureus Pneumonia. https://app.cochat.ai/papers/10.1128/iai.00115-09
- The paper
- Ragle, B. E., & Bubeck Wardenburg, J. (2009). Anti-Alpha-Hemolysin Monoclonal Antibodies Mediate Protection against Staphylococcus aureus Pneumonia. Infection and Immunity. https://doi.org/10.1128/iai.00115-09
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.